Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | REGN | GILD | ||
| Company | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals | Gilead Sciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 47.93 | 901.26 | 67.01 | ||
| High | 48.41 | 908.81 | 67.02 | ||
| Low | 47.62 | 891.67 | 65.90 | ||
| Last | 48.30 | 893.99 | 66.16 | ||
| Change | +0.46 | -7.20 | -0.77 | ||
| % Change | +0.96% | -0.80% | -1.15% | ||
| Volume | 10,917,500 | 450,600 | 6,442,200 | ||
| 20-Day Average Volume | 11,419,555 | 434,065 | 6,214,910 | ||
| Previous Close | 47.84 | 901.19 | 66.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 50.99 | 938.74 | 70.21 | ||
| 20-Day Raw Stochastic | 9.99% | 4.01% | 3.10% | ||
| 20-Day Relative Strength | 37.48% | 33.38% | 27.91% | ||
| Weighted Alpha | -30.16 | +11.94 | -25.27 | ||
| Today's Opinion | 72% Sell | 24% Buy | 100% Sell | ||
| Previous Opinion | 56% Sell | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 24% Sell | 80% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 04/11/24 | -2.86% since 04/11/24 | -3.63% since 04/11/24 | ||
| Low | 47.62 on 04/18/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 | ||
| High | 49.10 on 04/15/24 | 921.12 on 04/15/24 | 68.62 on 04/12/24 | ||
| 1-Month | |||||
| %Chg | -6.38% since 03/18/24 | -6.87% since 03/18/24 | -9.69% since 03/18/24 | ||
| Low | 47.62 on 04/18/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 | ||
| High | 54.47 on 03/28/24 | 979.26 on 03/21/24 | 74.28 on 03/21/24 | ||
| 3-Month | |||||
| %Chg | -3.57% since 01/18/24 | -3.87% since 01/18/24 | -23.43% since 01/18/24 | ||
| Low | 47.58 on 02/06/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 | ||
| High | 55.03 on 03/13/24 | 998.33 on 02/28/24 | 87.86 on 01/19/24 | ||
| 6-Month | |||||
| %Chg | -15.04% since 10/18/23 | +8.23% since 10/18/23 | -16.96% since 10/18/23 | ||
| Low | 47.58 on 02/06/24 | 769.19 on 10/27/23 | 65.90 on 04/18/24 | ||
| High | 57.09 on 10/20/23 | 998.33 on 02/28/24 | 87.86 on 01/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 96,960,152 | 98,916,416 | 83,333,008 | ||
| Shares Outstanding, K | 2,026,759 | 109,762 | 1,245,077 | ||
| Annual Sales | 45,006,000,000 | 13,117,200,000 | 27,116,000,000 | ||
| Annual Net Income | 8,025,000,000 | 3,953,600,000 | 5,665,000,000 | ||
| Last Quarter Sales | 11,477,000,000 | 3,434,300,000 | 7,114,000,000 | ||
| Last Quarter Net Income | 1,762,000,000 | 1,159,600,000 | 1,429,000,000 | ||
| 60-Month Beta | 0.39 | 0.11 | 0.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/02/24 | 11.86 on 02/02/24 | 1.72 on 02/06/24 | ||
| Latest Earnings Date | 04/25/24 | 05/02/24 | 04/25/24 | ||
| Most Recent Dividend | 0.600 on 04/04/24 | N/A | 0.770 on 03/14/24 | ||
| Next Ex-Dividends Date | 04/04/24 | N/A | 03/14/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 6.43 | 23.79 | 10.02 | ||